J9390 Vinorelbine tartrate injection
Also known as: vinorelbine, Navelbine
Injection of vinorelbine tartrate, a semi-synthetic vinca alkaloid. Used for non-small cell lung cancer and breast cancer.
In Plain Language
lung cancer chemotherapy injection; vinca alkaloid cancer drug
Clinical Context
Used for non-small cell lung cancer as single agent or combined therapy. Also used for metastatic breast cancer.
RVU Information
CPT J9390 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9390?
CPT J9390 (Vinorelbine tartrate injection) is a J Codes (Drugs) code. Injection of vinorelbine tartrate, a semi-synthetic vinca alkaloid. Used for non-small cell lung cancer and breast cancer.
How is J9390 administered?
CPT J9390 is administered by a healthcare provider, typically via injection or infusion. Used for non-small cell lung cancer as single agent or combined therapy. Also used for metastatic breast cancer. It is used by Oncology, Pulmonology, Surgery.
When is CPT J9390 used?
Used for non-small cell lung cancer as single agent or combined therapy. Also used for metastatic breast cancer.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.